Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-24

Clinical Trial Update: Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating octreotide for preventing pancreatic fistula after pancreaticoduodenectomy in patients with a soft pancreas (study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: PVS Memorial Hospital | Conditions: Pancreatic Fistula | Phase 4 | Status: COMPLETED